1,639
Views
18
CrossRef citations to date
0
Altmetric
Report

Altered expression of G1/S phase cell cycle regulators in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise

ORCID Icon, , , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 200-212 | Received 16 Aug 2016, Accepted 11 Nov 2016, Published online: 28 Dec 2016

References

  • Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecologic Oncology 2001; 82:238-46; PMID:11531273; http://dx.doi.org/10.1006/gyno.2001.6306
  • Milde-Langosch K, Riethdorf S. Role of cell-cycle regulatory proteins in gynecological cancer. Journal of Cellular Physiology 2003; 196:224-44; PMID:12811815; http://dx.doi.org/10.1002/jcp.10286
  • Funk JO. Cancer cell cycle control. Anticancer Research 1999; 19:4772-80; PMID:10697591
  • Rahat B, Hamid A, Ahmad Najar R, Bagga R, Kaur J. Epigenetic mechanisms regulate placental c-myc and hTERT in normal and pathological pregnancies; c-myc as a novel fetal DNA epigenetic marker for pre-eclampsia. Molecular human reproduction 2014; 20:1026-40; PMID:25024139; http://dx.doi.org/10.1093/molehr/gau053
  • Strickland S, Richards WG. INVASION OF THE TROPHOBLASTS. Cell 1992; 71:355-7; PMID:1423599; http://dx.doi.org/10.1016/0092-8674(92)90503-5
  • Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Human Reproduction Update 2007; 13:121-41; PMID:17068222; http://dx.doi.org/10.1093/humupd/dml048
  • Ray JE, Garcia J, Jurisicova A, Caniggia I. Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia. Cell Death Differ 2010; 17:846-59; PMID:19942931; http://dx.doi.org/10.1038/cdd.2009.167
  • Pijnenborg R, Vercruysse L, Verbist L, Van Assche FA. Interaction of interstitial trophoblast with placental bed capillaries and venules of normotensive and pre-eclamptic pregnancies. Placenta 1998; 19:569-75; PMID:9859859; http://dx.doi.org/10.1016/S0143-4004(98)90016-9
  • Rolfo A, Giuffrida D, Nuzzo AM, Pierobon D, Cardaropoli S, Piccoli E, Piccoli E, Giovarelli M, Todros T. Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. PLoS One 2013; 8:e59403; PMID:23527185; http://dx.doi.org/10.1371/journal.pone.0059403
  • Nuzzo AM, Giuffrida D, Zenerino C, Piazzese A, Olearo E, Todros T, et al. JunB/Cyclin-D1 imbalance in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise. Placenta 2014; 35:483-90; PMID:24780198; http://dx.doi.org/10.1016/j.placenta.2014.04.001
  • Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 22:649-58; PMID:15342929; http://dx.doi.org/10.1634/stemcells.22-5-649
  • Li C, Zhang W, Jiang X, Mao N. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Cell and Tissue Research 2007; 330:437-46; PMID:17899199; http://dx.doi.org/10.1007/s00441-007-0504-5
  • Demir R, Kaufmann P, Castellucci M, Erbengi T, Kotowski A. FETAL VASCULOGENESIS AND ANGIOGENESIS IN HUMAN PLACENTAL VILLI. Acta Anatomica 1989; 136:190-203; PMID:2481376; http://dx.doi.org/10.1159/000146886
  • Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J 2000; 19:2056-68; PMID:10790372; http://dx.doi.org/10.1093/emboj/19.9.2056
  • Passegue E, Wagner EF. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J 2000; 19:2969-79; PMID:10856241; http://dx.doi.org/10.1093/emboj/19.12.2969
  • Andrecht S, Kolbus A, Hartenstein B, Angel P, Schorpp-Kistner M. Cell cycle promoting activity of JunB through cyclin A activation. J Biol Chem 2002; 277:35961-8; PMID:12121977; http://dx.doi.org/10.1074/jbc.M202847200
  • Berthet C, Kaldis P. Cell-specific responses to loss of cyclin-dependent kinases. Oncogene 2007; 26:4469-77; PMID:17297466; http://dx.doi.org/10.1038/sj.onc.1210243
  • Parolini O, Alviano F, Bergwerf I, Boraschi D, De Bari C, De Waele P, et al. Toward Cell Therapy Using Placenta-Derived Cells: Disease Mechanisms, Cell Biology, Preclinical Studies, and Regulatory Aspects at the Round Table. Stem Cells and Development 2010; 19:143-54; PMID:19947828; http://dx.doi.org/10.1089/scd.2009.0404
  • Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007; 21:304-10; PMID:17170725; http://dx.doi.org/10.1038/sj.leu.2404489
  • DeLoia JA, Burlingame JM, Krasnow JS. Differential expression of G1 cyclins during human placentogenesis. Placenta 1997; 18:9-16; PMID:9032805; http://dx.doi.org/10.1016/S0143-4004(97)90066-7
  • Dai Y, Qiu Z, Diao Z, Shen L, Xue P, Sun H, et al. MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1. Placenta 2012; 33:824-9; PMID:22858023; http://dx.doi.org/10.1016/j.placenta.2012.07.012
  • Mando C, Razini P, Novielli C, Anelli GM, Belicchi M, Erratico S, et al. Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction. Stem Cells Transl Med 2016; 5:451-63; PMID:26956210; http://dx.doi.org/10.5966/sctm.2015-0155
  • Chen CP, Huang JP, Chu TY, Aplin JD, Chen CY, Wu YH. Human placental multipotent mesenchymal stromal cells modulate trophoblast migration via Rap1 activation. Placenta 2013; 34:913-23; PMID:23896030; http://dx.doi.org/10.1016/j.placenta.2013.06.311
  • Hwang JH, Lee MJ, Seok OS, Paek YC, Cho GJ, Seol HJ, et al. Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies. Cytokine 2010; 49:95-101; PMID:19819721; http://dx.doi.org/10.1016/j.cyto.2009.08.013
  • Neganova I, Lako M. G1 to S phase cell cycle transition in somatic and embryonic stem cells. Journal of Anatomy 2008; 213:30-44; PMID:18638068; http://dx.doi.org/10.1111/j.1469-7580.2008.00931.x
  • Sherr CJ, Roberts JM. INHIBITORS OF MAMMALIAN G(1) CYCLIN-DEPENDENT KINASES. Genes & Development 1995; 9:1149-63; PMID:7758941; http://dx.doi.org/10.1101/gad.9.10.1149
  • Schwaller J, Pabst T, Koeffler HP, Niklaus G, Loetscher P, Fey MF, et al. Expression and regulation of G(1) cell-cycle inhibitors (p16(INK4A), p15(INK4B), p18(INK4C), p19(INK4D)) in human acute myeloid leukemia and normal myeloid cells. Leukemia 1997; 11:54-63; PMID:9001419; http://dx.doi.org/10.1038/sj.leu.2400522
  • Piechaczyk M, Farras R. Regulation and function of JunB in cell proliferation. Biochemical Society Transactions 2008; 36:864-7; PMID:18793152; http://dx.doi.org/10.1042/BST0360864
  • Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 2009; 11:59-98; PMID:18976161; http://dx.doi.org/10.1089/ars.2008.2104
  • Biron-Shental T, Sukenik-Halevy R, Sharon Y, Laish I, Fejgin MD, Amiel A. Telomere shortening in intra uterine growth restriction placentas. Early Hum Dev 2014; 90:465-9; PMID:25010904; http://dx.doi.org/10.1016/j.earlhumdev.2014.06.003
  • D'Ippolito S, Di Nicuolo F, Marana R, Castellani R, Stinson J, Tersigni C, et al. Emerging nonanticoagulant role of low molecular weight heparins on extravillous trophoblast functions and on heparin binding-epidermal growth factor and cystein-rich angiogenic inducer 61 expression. Fertility and Sterility 2012; 98:1028-+; PMID:22818289; http://dx.doi.org/10.1016/j.fertnstert.2012.06.042
  • Smith SC, Price E, Hewitt MJ, Symonds EM, Baker PN. Cellular proliferation in the placenta in normal human pregnancy and pregnancy complicated by intrauterine growth restriction. J Soc Gynecol Investig 1998; 5:317-23; PMID:9824812; http://dx.doi.org/10.1016/S1071-5576(98)00035-5
  • Hara E, Smith R, Parry D, Tahara H, Steven S, Peters G. Regulation of p16(CDKN2) expression and its implications for cell immortalization and senescence. Molecular and Cellular Biology 1996; 16:859-67; PMID:8622687; http://dx.doi.org/10.1128/MCB.16.3.859
  • Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98:1076-84; PMID:16619257; http://dx.doi.org/10.1002/jcb.20886
  • Tetta C, Consiglio AL, Bruno S, Tetta E, Gatti E, Dobreva M, et al. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles Ligaments Tendons J 2012; 2:212-21; PMID:23738299
  • Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 2010; 19:667-79; PMID:20525442; http://dx.doi.org/10.3727/096368910X508762
  • Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Abomaray FM, et al. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages. Stem Cell Rev 2013; 9:620-41; PMID:23812784; http://dx.doi.org/10.1007/s12015-013-9455-2
  • Pianta S, Magatti M, Vertua E, Bonassi Signoroni P, Muradore I, Nuzzo AM, et al. Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls. J Cell Mol Med 2016; 20(1):157-69; PMID:26515425; http://dx.doi.org/10.1111/jcmm.12715
  • Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105:2821-7; PMID:15591115; http://dx.doi.org/10.1182/blood-2004-09-3696
  • Rolfo A, Giuffrida D, Giuffrida MC, Todros T, Calogero AE. New perspectives for prostate cancer treatment: in vitro inhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media. Aging Male 2014; 17:94-101; PMID:24597941; http://dx.doi.org/10.3109/13685538.2014.896894
  • Qin S, Jiang H, Su S, Wang D, Liang Z, Zhang J, et al. Inhibition of hepatic stellate cell proliferation by bone marrow mesenchymal stem cells via regulation of the cell cycle in rat. Exp Ther Med 2012; 4:375-80; PMID:23181102
  • Munoz-Espin D, Canamero M, Maraver A, Gomez-Lopez G, Contreras J, Murillo-Cuesta S, et al. Programmed cell senescence during mammalian embryonic development. Cell 2013; 155:1104-18; PMID:24238962; http://dx.doi.org/10.1016/j.cell.2013.10.019
  • Sheppard KE, McArthur GA. The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma. Clin Cancer Res 2013; 19:5320-8; PMID:24089445; http://dx.doi.org/10.1158/1078-0432.CCR-13-0259
  • Lee JH, Park CH, Chun KH, Hong SS. Effect of adipose-derived stem cell-conditioned medium on the proliferation and migration of B16 melanoma cells. Oncol Lett 2015; 10:730-6; PMID:26622561
  • Ooi YY, Dheen ST, Tay SS. Paracrine effects of mesenchymal stem cells-conditioned medium on microglial cytokines expression and nitric oxide production. Neuroimmunomodulation 2015; 22:233-42; PMID:25341618; http://dx.doi.org/10.1159/000365483
  • Chen J, Li Y, Hao H, Li C, Du Y, Hu Y, et al. Mesenchymal Stem Cell Conditioned Medium Promotes Proliferation and Migration of Alveolar Epithelial Cells under Septic Conditions In Vitro via the JNK-P38 Signaling Pathway. Cell Physiol Biochem 2015; 37:1830-46; PMID:26584283; http://dx.doi.org/10.1159/000438545
  • Wu F, Tian FJ, Lin Y. Oxidative Stress in Placenta: Health and Diseases. Biomed Res Int 2015; 2015:293271; PMID:26693479.
  • Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest 2000; 105:1663-8; PMID:10862779; http://dx.doi.org/10.1172/JCI10413
  • Fukada S, Ma Y, Uezumi A. Adult stem cell and mesenchymal progenitor theories of aging. Front Cell Dev Biol 2014; 2:10; PMID:25364718; http://dx.doi.org/10.3389/fcell.2014.00010
  • Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 2008; 26:151-62; PMID:17932421; http://dx.doi.org/10.1634/stemcells.2007-0416
  • Roland CS, Hu J, Ren CE, Chen H, Li J, Varvoutis MS, et al. Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia. Cell Mol Life Sci 2016; 73(2):365-76; PMID:26496726; http://dx.doi.org/10.1007/s00018-015-2069-x
  • Chuprin A, Gal H, Biron-Shental T, Biran A, Amiel A, Rozenblatt S, et al. Cell fusion induced by ERVWE1 or measles virus causes cellular senescence. Genes Dev 2013; 27:2356-66; PMID:24186980; http://dx.doi.org/10.1101/gad.227512.113
  • Goldman-Wohl D, Yagel S. United we stand not dividing: the syncytiotrophoblast and cell senescence. Placenta 2014; 35:341-4; PMID:24709558; http://dx.doi.org/10.1016/j.placenta.2014.03.012
  • Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449:557-63; PMID:17914389; http://dx.doi.org/10.1038/nature06188
  • De Falco M, Fedele V, Cobellis L, Mastrogiacomo A, Giraldi D, Leone S, et al. Pattern of expression of cyclin D1/CDK4 complex in human placenta during gestation. Cell Tissue Res 2004; 317:187-94; PMID:15221443; http://dx.doi.org/10.1007/s00441-004-0880-z
  • Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7:812-21; PMID:8491378; http://dx.doi.org/10.1101/gad.7.5.812
  • Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12:3499-511; PMID:9832503; http://dx.doi.org/10.1101/gad.12.22.3499
  • Alt JR, Cleveland JL, Hannink M, Diehl JA. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000; 14:3102-14; PMID: 11124803; http://dx.doi.org/10.1101/gad.854900
  • Bertino E, Di Battista E, Bossi A, Pagliano M, Fabris C, Aicardi G, et al. Fetal growth velocity: kinetic, clinical, and biological aspects. Arch Dis Child Fetal Neonatal Ed 1996; 74:F10-5; PMID:8653429; http://dx.doi.org/10.1136/fn.74.1.F10
  • Parazzini F, Cortinovis I, Bortolus R, Fedele L. [Standards of birth weight in Italy]. Ann Ostet Ginecol Med Perinat 1991; 112:203-46; PMID:1807187
  • Ferrazzi E, Zullino S, Stampalija T, Vener C, Cavoretto P, Gervasi MT, et al. Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol 48:224-31; PMID:26350023; http://dx.doi.org/10.1002/uog.15741
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262